Economic Evaluation of Voriconazole for the Treatment of Candidemia in Canadian Adults

BACKGROUND: Candidemia is a common cause of nosocomial bloodstream infection. When selecting therapeutic treatments for candidemia, cost-effectiveness is an important consideration. The present study assessed the cost-effectiveness of voriconazole for the treatment of candidemia.

Saved in:
Bibliographic Details
Main Authors: Coleman Rotstein, Lael Cragin, Michel Laverdière, Gary Garber, Eric J Bow, Alissa Scalera, Craig Roberts, Sonja V Sorenson, the Canadian Expert Panel
Format: Article
Language:English
Published: Wiley 2008-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2008/161835
Tags: Add Tag
No Tags, Be the first to tag this record!